Prev  |  Next
Unthreaded  |  Threaded Author Recs Date Number
Q1 sales +25%, profit +13% TMFCogitarius -- 5/9/2012 8:02 AM 81
New CEO buys time on outlook TMFCogitarius 2 5/10/2012 7:56 AM 82
30 new product launches ahead TMFCogitarius 2 5/15/2012 11:59 AM 83
New CEO cuts 2012 forecast TMFCogitarius -- 5/24/2012 10:07 AM 84
Strong results on Treanda TMFCogitarius -- 6/4/2012 11:59 AM 85
Long acting Copaxone meets trial goals TMFCogitarius -- 6/18/2012 11:33 AM 86
Q2 sales +19%, profit +14% TMFCogitarius 2 8/3/2012 12:52 PM 88
FDA approves Neupogen biosimilar TMFCogitarius 2 8/30/2012 2:10 PM 89
Copaxone II results positive TMFCogitarius 1 10/10/2012 1:31 PM 90
Re: Is now a good time to start buying TEVA? TMFCogitarius -- 6/7/2013 11:02 AM 92
Q&A with Teva CFO TMFCogitarius 1 6/13/2013 12:05 PM 94
Re: TEVA down premarket TMFDoraemon 2 4/21/2011 9:40 AM 9
Re: Novartis sues to block generic transplant dr TMFDoraemon 1 4/21/2011 11:08 AM 11
Re: TEVA down premarket TMFDoraemon -- 4/21/2011 12:50 PM 13
Re: Novartis sues to block generic transplant dr TMFDoraemon 1 4/21/2011 2:01 PM 16
Re: TEVA down premarket TMFDoraemon 1 4/21/2011 2:54 PM 18
Re: Novartis vs. Teva TMFDoraemon 7 4/25/2011 3:38 PM 22
Re: Novartis vs. Teva TMFDoraemon -- 4/26/2011 1:40 PM 24
Teva acquiring Cephalon TMFDoraemon 5 5/2/2011 8:28 AM 26
Teva Making Another Deal? TMFDoraemon 4 5/3/2011 10:24 AM 29
Prev  |  Next